Alibaba Health Information Technology Limited (ALBBY)
Company Info
| Sector | Healthcare |
|---|---|
| Industry | Pharmaceutical Retailers |
Highlights
| Market Cap | $6.05B |
|---|---|
| EPS (TTM) | $0.18 |
| PE Ratio | 41.78 |
| PEG Ratio | 0.89 |
| Total Revenue (TTM) | $3.77B |
| Gross Profit (TTM) | $821.96M |
| EBITDA (TTM) | $95.96M |
| Year Range | $6.88 - $12.43 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Alibaba Health Information Technology Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Alibaba Health Information Technology Limited had a return of -30.37% year-to-date (YTD) and -29.72% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -30.37% | 13.39% |
| 1 month | -2.72% | 4.02% |
| 6 months | -4.81% | 5.56% |
| 1 year | -29.72% | 21.51% |
| 5 years (annualized) | N/A | 12.69% |
| 10 years (annualized) | N/A | 10.55% |
Monthly Returns
The table below presents the monthly returns of ALBBY, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -25.93% | 8.87% | 3.33% | -23.44% | 26.80% | -1.33% | -3.44% | -9.65% | -30.37% | ||||
| 2023 | 7.92% | -24.91% | 1.29% | 0.00% | -12.44% | -5.28% | 17.21% | -24.11% | 16.12% | -6.32% | 4.21% | -10.96% | -38.88% |
| 2022 | -8.52% | -6.15% | -6.68% | -24.40% | 5.76% | 29.32% | -4.45% | -12.29% | -19.50% | -8.76% | 93.01% | 8.47% | 6.77% |
| 2021 | 3.96% | 8.85% | -16.00% | 5.88% | -19.07% | -7.24% | -32.08% | 7.35% | -19.90% | -5.57% | -27.46% | -10.25% | -72.88% |
| 2020 | 0.00% | 0.00% | 0.00% | 0.00% | 193.45% | 18.35% | 0.08% | -18.03% | -6.02% | 15.13% | -4.74% | 18.40% | 247.69% |
| 2019 | 0.00% | 0.00% | 0.00% | 0.00% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of ALBBY is 19, indicating that it is in the bottom 19% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Alibaba Health Information Technology Limited (ALBBY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Alibaba Health Information Technology Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Alibaba Health Information Technology Limited was 91.29%, occurring on Apr 15, 2024. The portfolio has not yet recovered.
The current Alibaba Health Information Technology Limited drawdown is 90.48%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -91.29% | Feb 18, 2021 | 794 | Apr 15, 2024 | — | — | — |
| -24.33% | Aug 31, 2020 | 6 | Sep 8, 2020 | 64 | Dec 8, 2020 | 70 |
| -22.61% | Dec 22, 2020 | 4 | Dec 28, 2020 | 15 | Jan 20, 2021 | 19 |
| -12.55% | Jan 22, 2021 | 6 | Jan 29, 2021 | 11 | Feb 16, 2021 | 17 |
| -2.79% | Jul 6, 2020 | 1 | Jul 6, 2020 | 3 | Jul 9, 2020 | 4 |
Volatility
Volatility Chart
The current Alibaba Health Information Technology Limited volatility is 2.75%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Alibaba Health Information Technology Limited compared to its peers in the Pharmaceutical Retailers industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for ALBBY in comparison to other companies of the Pharmaceutical Retailers industry. Currently, ALBBY has a PE value of 41.8. This PE ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for ALBBY in comparison to other companies of the Pharmaceutical Retailers industry. Currently, ALBBY has a PEG value of 0.9. This PEG ratio falls in the average range for the industry.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Alibaba Health Information Technology Limited.
Loading data...
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
| Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
| Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |